World Journal of Endocrine Surgery

Register      Login

VOLUME 6 , ISSUE 2 ( May-August, 2014 ) > List of Articles


Heterogenous Morphologic forms of Goiter in Autoimmune thyroid disease: An Insight based on a Prospective Surgical series of 88 cases

Bhargav PRK

Citation Information : PRK B. Heterogenous Morphologic forms of Goiter in Autoimmune thyroid disease: An Insight based on a Prospective Surgical series of 88 cases. World J Endoc Surg 2014; 6 (2):71-76.

DOI: 10.5005/jp-journals-10002-1140

Published Online: 01-08-2017

Copyright Statement:  Copyright © 2014; The Author(s).


How to cite this article

Bhargav PRK. Heterogenous Morphologic forms of Goiter in Autoimmune thyroid disease: An Insight based on a Prospective Surgical series of 88 cases. World J Endoc Surg 2014;6(2):71-76.

PDF Share
  1. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7(6):481-493.
  2. American thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19(11):1167-1214.
  3. Current concepts of thyroiditis. Arch Intern Med 1983;143(10):1952-1956.
  4. Clinical endocrinology in India. Current Science 2000;79(8):1061-1067.
  5. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002;12(10):839-847.
  6. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves’ patients. Eur J Endocrinol 2011;164(5):789-794.
  7. Thyroiditis. N Engl J Med 2003;348(26):2646-2655.
  8. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 1974;38(6):976-998.
  9. thyroid nodules in graves disease and the risk of thyroid carcinoma. Arch Intern Med 1999;159(9):1705-1708.
  10. Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country. World J Surg 2007 Feb;31(2):306-312.
  11. Thyroid nodules associated with Hashimoto's thyroiditis: assessment with US. Radiology 1992;185(1):125-130.
  12. Declaration of Helsinki. BMJ 1996;313:1448-1449.
  13. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 1992;26(6):885.
  14. Autoimmune phenomena in periniocious anemia: serological overlap with thyroiditis, thyrotoxicosis, and systemic lupus erythematosus. BMJ 1963;1(5342):1374-1379.
  15. Easy bruising, thyrombocytopenia, and elevated platelet immunoglobulin G in Graves'disease and Hashimoto's thyroiditis. Ann Intern Med 1981;94(1):27.
  16. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 2010;123(2):183.
  17. The thyrotropin receptor: Interaction with thyrotropin and autoantibodies. Endocr Rev 1998;19(6):673-716.
  18. Thyroiditis: a clinical review. Am Fam Physician 1993;48(4):615-621.
  19. Graves’ disease associated with histologic Hashioto's thyroiditis. Otolaryngol Head Neck Surg 1985;93(1):86-91.
  20. Hypothyroidism as a late sequela in patient with Graves’ disease treated with antithyroid agents. J Clin Invest 1979;64(5);1429-1436.
  21. Apathetic hyperthyroidism in an adolescent. J Psychiatry Neurosci 1993;18(5):276.
  22. The ABCs of managing hyperthyroidism in the older patient. Geriatrics 1996;51(5):22-24.
  23. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996;44(1):50-53.
  24. Goitre size and outcome of medical treatment of Graves’ disease. Acta Endocrinol (Copenh) 1986;111(1):39-43.
  25. J Pediatr 2005;146(4):533-536.
  26. Hashimoto disease with hyperthyroid ocular signs. Metab Pediat Ophthalmol 1981;5(3-4):213-218.
  27. Management of Graves’ ophthalmopathy: reality and perspetives. Endocrine Rev 2000;21(2):168-199.
  28. The Link between Graves’ disease and Hashimoto's thyroiditis: a role for regulatory. T Cells Endocrinology 2007;148(12):5724-5733.
  29. Hashimoto's thyroiditis following Graves’ disease. Acta Med Indones 2010;42(1):31-35.
  30. Comparison of the prevalence and sonographic features of thyroid nodules accompanying autoimmune thyroid diseases. Endokrynol Pol 2010;61(6):658-664.
  31. The Marine-Lenhart syndrome revisited. Wien Klin Wochenschr 2011;123(15-16):459-462.
  32. The genetics of Graves’ disease. HLA and disease susceptilbility. J Clin Endocrinol Metab 1985;61(4):735-740.
  33. Association of Graves’ disease with an allele of the interleukin-I receptor antagonist gene. J Clin Endocrinol Metab 1995;80(1):111-115.
  34. The prevention of simple goiter in man. J Lab Clin Med 1917;3:40-48.
  35. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab 1998;83(1):130-134.
  36. Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 2001;109(5):250-260.
  37. Reading, MD solitary thyroid nodule comparison between palpation and ultrasonography. Arch Intern Med 1995;155(22):2418-2423.
  38. Sonographic appearance of focal thyroiditis. AJR 2001;176(3):751-754.
  39. Surgical indications for goiter with background Hashimoto's thyroiditis: Institutional experience. Indian J Surg 2011;73(6):414-418.
  40. Thyroid nodules in Graves’ disease: classification, characterization, and response to treatment. Thyroid 1998;8(8):647-652.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.